The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Seminars in Medicine of the Beth Israel Deaconess Medical Center
PreviousPrevious
Volume 330:839-846 March 24, 1994 Number 12
NextNext

Cytokine Receptors in Congenital Hematopoietic Disease
Alan D. D'Andrea

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Hematopoietic growth factors promote both growth and differentiation of blood cells1,2. These factors activate specific hematopoietic growth factor receptors that are expressed on the surface of blood progenitor cells of the bone marrow. The past decade has witnessed the identification and cloning of several genes for hematopoietic growth factors and growth factor receptors. The availability of the complementary DNA encoding these polypeptides has provided tools for understanding the normal process of blood-cell production and the abnormal processes of leukemia and other diseases in humans.

Hematopoietic Growth Factors

The identification of hematopoietic growth factors was made possible primarily by the cell-culture assays for . . . [Full Text of this Article]

Hematopoietic Growth Factor Receptors

Cytokine Receptors in Congenital Disease

Familial Erythrocytosis

X-Linked Severe Combined Immunodeficiency

Kostmann's Syndrome

Laron Dwarfism

Other Congenital Diseases

Implications for Diagnosis and Therapeutic Intervention

Implications for the Study of Biologic Aspects of Receptors

Conclusions

Discussion


Source Information

From the Division of Pediatric Oncology and the Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.

Address reprint requests to Dr. D'Andrea at the Division of Pediatric Oncology and the Division of Cellular and Molecular Biology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.